Literature DB >> 22428432

Postoperative nutrition of neonates undergoing heart surgery.

L Rosti1, T Vivaldo, G Butera, M Chessa, C Carlucci, A Giamberti.   

Abstract

OBJECTIVE: Postoperative nutrition of newborns undergoing heart surgery (HS) is ill-defined. We compared the postoperative growth rates (grams/day) of neonates with congenital heart defects (CHDs) fed with their own mothers' milk (HU), a starting formula (SF; 67 kcal/100 mL), or a "preterm formula" (PF; 80 kcal/100 mL). PATIENTS AND METHODS: We studied 122 newborns undergoing HS: 81 underwent corrective surgery (group A), and 41 palliative surgery (group B).
RESULTS: No statistically significant differences were found in the growth rate between group A and B. Moreover, in both groups, no differences in terms of growth rate between infants fed HU, SF, or PF were observed. This was also true when analyses were limited to infants undergoing HS either with or without cardiopulmonary bypass.
CONCLUSIONS: In neonates undergoing HS, human milk allowed a growth rate similar to that observed with starting formulas and "preterm formulas". This effect may depend on the particular features of human milk and its protective properties for the intestinal mucosa.

Entities:  

Mesh:

Year:  2011        PMID: 22428432

Source DB:  PubMed          Journal:  Pediatr Med Chir        ISSN: 0391-5387


  2 in total

1.  The experience of breastfeeding infants affected by congenital diaphragmatic hernia or esophageal atresia.

Authors:  G Salvatori; S Foligno; M Massoud; F Piersigilli; P Bagolan; A Dotta
Journal:  Ital J Pediatr       Date:  2018-07-03       Impact factor: 2.638

Review 2.  Enteral Nutrition in Term Infants with Congenital Heart Disease: Knowledge Gaps and Future Directions to Improve Clinical Practice.

Authors:  Silvia Martini; Isadora Beghetti; Mariarosaria Annunziata; Arianna Aceti; Silvia Galletti; Luca Ragni; Andrea Donti; Luigi Corvaglia
Journal:  Nutrients       Date:  2021-03-13       Impact factor: 5.717

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.